SOPH Q2 2022 Earnings — SOPHiA GENETICS S.A. Revenue & Financial Results | Market Cap Arena

SOPHSOPHiA GENETICS S.A.

$308M

Q2 2022 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$12M+14.6% YoY

Gross Profit

$8M65.3% margin

Operating Income

-$24M-206.4% margin

Net Income

-$25M-211.5% margin

EPS (Diluted)

$-0.39

QoQ Revenue Growth

+7.4%

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$22M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$277M

Total Liabilities

$49M

Stockholders' Equity

$228M

Cash & Equivalents

$179M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$10M	+14.6%
Gross Profit	$8M	$6M	+22.3%
Operating Income	-$24M	-$16M	-51.2%
Net Income	-$25M	-$18M	-34.2%